Business Description
Oncolytics Biotech Inc. is a Canadian company founded in 1998 and based in Calgary, focused on developing new ways to fight cancer. Its main work centers on a drug called pelareorep, which is given through an IV and helps the body's immune system attack tumors in conditions such as breast cancer, pancreatic cancer, and anal cancer. The company works alongside Roche Holding AG, which provides a complementary drug used in Oncolytics' ongoing clinical trials.
